婦產科
子宮收縮劑(Uterotonic Agents)
Randomized controlled trial comparing carbetocin, misoprostol, and oxytocin for the prevention of postpartum hemorrhage following an elective cesarean delivery. (開啟新視窗)
出處: Int J Gynaecol Obstet 2016;134(3):324-8.
檢索: PubMed 27350226
Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis. (開啟新視窗)
出處: Cochrane Database Syst Rev 2018;4:CD011689.
檢索: PubMed 29693726
DOI碼: 10.1002/14651858.CD011689.pub2
Preventing postpartum hemorrhage after cesarean delivery: A network meta-analysis of available pharmacologic agents. (開啟新視窗)
出處: Am J Obstet Gynecol.
檢索: PubMed 34534498
DOI碼: 10.1016/j.ajog.2021.08.060
A randomised controlled trial comparing oxytocin and oxytocin + ergometrine for prevention of postpartum haemorrhage at caesarean section. (開啟新視窗)
出處: S Afr Med J 2016;106(4):399-402.
檢索: PubMed 27032858
Prophylactic use of ergot alkaloids in the third stage of labour. (開啟新視窗)
出處: Cochrane Database Syst Rev 2007;(2):CD005456.
檢索: PubMed 17443592
Treatment for primary postpartum haemorrhage. (開啟新視窗)
出處: Cochrane Database Syst Rev 2014;(2):CD003249.
檢索: PubMed 24523225
Comparison of two oxytocin regimens to prevent uterine atony at cesarean delivery: a randomized controlled trial. (開啟新視窗)
出處: Obstet Gynecol 2001;98(3):386-90.
檢索: PubMed 11530117
Prospective randomized trial of oxytocin administration for active management of the third stage of labor. (開啟新視窗)
出處: Int J Gynaecol Obstet 2014;127(2):175-9.
檢索: PubMed 25108586
A randomized clinical trial of preoperative versus postoperative misoprostol in elective cesarean delivery. (開啟新視窗)
出處: Int J Gynaecol Obstet 2016;132(1):82-4.
檢索: PubMed 26522140
DOI碼: 10.1016/j.ijgo.2015.06.057
Dose and duration of oxytocin to prevent postpartum hemorrhage: a review. (開啟新視窗)
出處: Am J Perinatol 2013;30(7):523-8.
檢索: PubMed 23208766
Prostaglandin E2 analogue sulprostone for treatment of atonic postpartum hemorrhage. (開啟新視窗)
出處: Obstet Gynecol 2011;118(2 Pt 1):257-65.
檢索: PubMed 21775840
DOI碼: 10.1097/AOG.0b013e3182255335
The effects of a peripartum strategy to prevent and treat primary postpartum haemorrhage at health facilities in Niger: a longitudinal, 72-month study. (開啟新視窗)
出處: Lancet Glob Health. 2023 11(2):e287-e295.
檢索: PubMed 36669809
DOI碼: 10.1016/S2214-109X(22)00518-6.
Intravenous sulprostone infusion in the treatment of retained placenta. (開啟新視窗)
出處: Acta Obstet Gynecol Scand 2013;92(4):426-32.
檢索: PubMed 22862433
DOI碼: 10.1111/j.1600-0412.2012.01506.x
Carbetocin for preventing postpartum haemorrhage. (開啟新視窗)
出處: Cochrane Database Syst Rev 2012;(4):CD005457.
檢索: PubMed 22513931
Prostaglandins for preventing postpartum haemorrhage. (開啟新視窗)
出處: Cochrane Database Syst Rev 2012;(8):CD000494.
檢索: PubMed 22895917
DOI碼: 10.1002/14651858.CD000494.pub4
Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage. (開啟新視窗)
出處: Cochrane Database Syst Rev 2013;(10):CD001808.
檢索: PubMed 24173606
DOI碼: 10.1002/14651858.CD001808.pub2